NCT04816903 is a NA clinical trial of Gyni in Vaginitis, sponsored by GynTools Ltd..

Who is sponsoring NCT04816903?

NCT04816903 is sponsored by GynTools Ltd..

What drugs are being tested in NCT04816903?

Interventions in NCT04816903: Gyni.

Is NCT04816903 still recruiting?

NCT04816903 is currently status unknown. Last updated 25 March 2021.

Last reviewed 2021-03-25 · How we verify

NCT04816903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gyni™ Study With Leumit Health Services

Status unknown NA Last updated 25 March 2021

What this trial tests

NA trial testing Gyni in Vaginitis in 600 participants. Status unknown.

Timeline

7 March 2021

Primary endpoint
7 March 2022

7 March 2022

Quick facts

Lead sponsor	GynTools Ltd.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	diagnostic
Enrollment	600
Start date	7 March 2021
Primary completion	7 March 2022
Estimated completion	7 March 2022
Sites	4 locations across Israel

Drugs / interventions tested

Gyni

Conditions studied

Vaginitis — all drugs for Vaginitis →

Sponsor

GynTools Ltd.

Who can join

Adults 18 to 99, female only, with Vaginitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

About one third of the women referring to gynecological clinics present with vulvovaginal inflammation symptoms (vaginitis) possibly caused by seven different conditions or mixed infections. The Gyni™ system is intended to provide physicians with the means to obtain an accurate, fast and inexpensive diagnosis which is unavailable today. Gyni™ is comprised of a compact tabletop scanner, a disposable sample collector and a cloud based algorithm that provides a suggested diagnosis within 5 minutes. The trial is a prospective evaluation of the cost-effectiveness of using Gyni™ by comparing its usage outcomes in a practice setting to the outcomes obtained using the current standard of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vaginitis

Currently open trials in the same condition.

NCT06771063 — A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients · Phase 2 · recruiting
NCT06070454 — Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant L · NA · recruiting
NCT04574089 — Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04816903 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GynTools Ltd.
Last refreshed: 25 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04816903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing